<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01105832</url>
  </required_header>
  <id_info>
    <org_study_id>2009-017320-29</org_study_id>
    <nct_id>NCT01105832</nct_id>
  </id_info>
  <brief_title>Does Teriparatide (rhPTH 1-34) Promote Fracture Healing in Proximal Humeral Fractures?</brief_title>
  <official_title>Påskyndar PTH läkningen av Konservativt Behandlade Humerusfrakturer?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Linkoeping</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Linkoeping</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      40 postmenopausal women, with a non-operated proximal humeral fracture, will be randomized to
      standard treatment (physiotherapy) or standard treatment + Forsteo (rhPTH 1-34) during 4
      weeks. Follow-up will be at 7 weeks and 3 months including x-ray and DASH score (The
      Disabilities of the Arm, Shoulder and Hand) measuring physical function, and pain on a visual
      analoge scale (VAS).

      Two doctors, blinded to the treatment, will judge the callus formation and healing on the
      x-rays and guess the treatment. The DASH score and the pain score will be compared between
      the treatment groups.

      The investigators hypotheses are that callus formation and healing will be more pronounced
      and that patients have less pain and better function in the rhPTH 1-34 group.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">February 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Callus formation and fracture healing at 7 weeks judged by a blinded assessor who will guess the treatment</measure>
    <time_frame>7 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Function</measure>
    <time_frame>7 weeks and 3 months</time_frame>
    <description>The function in the upper extremity will be measured using DASH. The experimental group will be compared with the control group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>7 weeks and 3 months</time_frame>
    <description>Pain at rest and during activity will be measured using a visual analogue scale (VAS). The experimental group will be compared with the control group</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Humeral Fracture</condition>
  <arm_group>
    <arm_group_label>Proximal humeral fracture - intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 patients will be randomized to 20 micrograms daily of Teriparatide (Forsteo)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Proximal humeral fracture</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>20 patients will receive standard treatment (physiotherapy)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Teriparatide</intervention_name>
    <description>Teriparatide (Forsteo) 20 micrograms daily during four weeks</description>
    <arm_group_label>Proximal humeral fracture - intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  proximal humeral fracture

          -  postmenopausal woman 50 years or older

          -  non-surgical treatment

        Exclusion Criteria:

          -  dementia or psychiatric disorder

          -  known malignancy &lt; 5 years prior to fracture

          -  calcium above reference value

          -  signs of liver disease

          -  creatinine over ref. value

          -  inflammatory joint disease

          -  alcohol or drug abuse

          -  oral corticosteroid medication

          -  long-term NSAID-treatment (=&gt; 3 months prior to fracture)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Lasarettet i Motala</name>
      <address>
        <city>Motala</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Orthopaedics</name>
      <address>
        <city>Norrköping</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <results_reference>
    <citation>Aspenberg P, Genant HK, Johansson T, Nino AJ, See K, Krohn K, García-Hernández PA, Recknor CP, Einhorn TA, Dalsky GP, Mitlak BH, Fierlinger A, Lakshmanan MC. Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res. 2010 Feb;25(2):404-14. doi: 10.1359/jbmr.090731.</citation>
    <PMID>19594305</PMID>
  </results_reference>
  <results_reference>
    <citation>Aspenberg P, Johansson T. Teriparatide improves early callus formation in distal radial fractures. Acta Orthop. 2010 Apr;81(2):234-6. doi: 10.3109/17453671003761946. Erratum in: Acta Orthop. 2010 Oct;81(5):647.</citation>
    <PMID>20367417</PMID>
  </results_reference>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 13, 2010</study_first_submitted>
  <study_first_submitted_qc>April 16, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 19, 2010</study_first_posted>
  <last_update_submitted>December 9, 2014</last_update_submitted>
  <last_update_submitted_qc>December 9, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 10, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Linkoeping</investigator_affiliation>
    <investigator_full_name>Torsten Johansson</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Teriparatide</keyword>
  <keyword>fracture healing</keyword>
  <keyword>proximal humeral fractures</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Humeral Fractures</mesh_term>
    <mesh_term>Shoulder Fractures</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Teriparatide</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>October 22, 2015</submitted>
    <returned>November 24, 2015</returned>
    <submitted>January 20, 2016</submitted>
    <returned>February 16, 2016</returned>
    <submitted>February 17, 2016</submitted>
    <returned>March 11, 2016</returned>
    <submitted>May 16, 2016</submitted>
    <returned>June 23, 2016</returned>
    <submitted>September 19, 2017</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

